IMP: Estimating the growth in quarter 3/2009 over 10%

Imexpharm Pharmaceutical Joint Stock Company (IMP: IMEXPHARM) has confirmed the business result in quarter 3/2009 as follows:

* The company has not completed a report of the business result in quarter 3/2009.

* However, the profit in quarter 3/2009 was estimated to increase 10% in comparison that in quarter 3/2008.

hose

>   CUONG THUAN IDICO CORP: HOSE receives listing registration documents (10/10/2009)

>   PET: Petrosetco buys 3 PTSC’s subsidiaries (10/10/2009)

>   VIP: Revenue & profit in September 2009 (10/10/2009)

>   HAP: Announcement of Bonus Stock Issuance (10/10/2009)

>   SRF: Announcement of the first trading date (10/10/2009)

>   TTP: Trading Result of Major Shareholder (10/10/2009)

>   FPT: Trading Result of Major Shareholder (10/10/2009)

>   NSC: Trading Result of Major Shareholder (10/10/2009)

>   SSC: Trading Result of Major Shareholder (10/10/2009)

>   NSC: Trading Result of Major Shareholder (10/10/2009)